Physician profile
Leon A Cohen
NPI 1558329607
$16,374.63
in general payments reported to CMS, 2019-2025
51 companies · $4,704 in 2025
The $4,704 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $498 · 2021: $1,346 · 2022: $1,247 · 2023: $3,585 · 2024: $4,457 · 2025: $4,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,745.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,502.61 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Janssen Pharmaceuticals, INC | $1,586.92 | 2019-2024 | Xarelto |
| Amgen INC. | $1,253.01 | 2019-2025 | Repatha, Otezla, Repatha |
| Abbvie INC. | $861.03 | 2021-2025 | Mavyret, Vraylar, Ubrelvy |
| Janssen Biotech, INC. | $545.18 | 2024-2025 | Rybrevant, Carvykti |
| E.R. Squibb & Sons, L.L.C. | $531.48 | 2019-2025 | Reblozyl, Opdivo, Abecma |
| Exact Sciences Corporation | $530.51 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $495.56 | 2022-2025 | |
| Vanda Pharmaceuticals INC. | $419.75 | 2024-2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $412.92 | 2025 | Caplyta |
| Genzyme Corporation | $369.13 | 2024-2025 | |
| Lilly USA, LLC | $336.80 | 2019-2024 | Jaypirca, Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $267.68 | 2023-2025 | Zejula, Shingrix, Arexvy |
| Kite Pharma, INC. | $248.92 | 2023-2024 | Yescarta |
| Eisai INC. | $248.20 | 2025 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.